IGC Pharma
IGC
#10720
Rank
โ‚น2.17 B
Marketcap
โ‚น18.64
Share price
-2.91%
Change (1 day)
-44.68%
Change (1 year)
IGC Pharma, Inc. (formerly India Globalization Capital, Inc.) is a clinical-stage pharmaceutical company focused on developing advanced treatments for diseases, with a primary focus on Alzheimer's disease and other neurological conditions.

Earnings for IGC Pharma (IGC)

Earnings in 2026 (TTM): -โ‚น0.59 Billion

According to IGC Pharma's latest financial reports the company's current earnings are โ‚น1.18 Million. In 2025 the company made an earning of -โ‚น0.51 Billion, an increase over its 2024 earnings that were of -โ‚น0.83 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for IGC Pharma from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น0.59 Billion17.29%
2025 -โ‚น0.51 Billion-39.35%
2024 -โ‚น0.83 Billion-37.72%
2023 -โ‚น1.33 Billion1.19%
2022 -โ‚น1.32 Billion21.96%
2021 -โ‚น1.08 Billion27.13%
2020 -โ‚น0.85 Billion57.16%
2019 -โ‚น0.54 Billion85.47%
2018 -โ‚น0.3 Billion52.76%
2017 -โ‚น0.2 Billion-16.23%
2016 -โ‚น0.23 Billion-28.75%
2015 -โ‚น0.32 Billion-19.59%
2014 -โ‚น0.4 Billion6.79%
2013 -โ‚น0.38 Billion-9.47%
2012 -โ‚น0.41 Billion-74.03%
2011 -โ‚น1.58 Billion119.78%
2010 -โ‚น0.72 Billion62.02%
2009 -โ‚น0.45 Billion74.39%
2008 -โ‚น0.26 Billion-313.12%
2007 โ‚น0.11 B-35.94%
2006 โ‚น0.18 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sterling Infrastructure
STRL
โ‚น73.31 B-12,021.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Trinity Industries
TRN
โ‚น68.58 B-11,253.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Granite Construction
GVA
-โ‚น6.25 Billion 915.47%๐Ÿ‡บ๐Ÿ‡ธ USA